(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoicacid-D4;N-[[2-(6-Benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-L-phenylalanine-d4; Xiidra;Lifitegrast-d4
Lifitegrast-d4 is a fully characterized chemical compound used as a reference standard of API Lifitegrast. The standard offered is compliant with regulatory guidelines. Lifitegrast-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1025967-78-5 (non-d)
Related products
Lifitegrast 3-(Propanamido)-3-(3(methylsulfonyl)phenyl)propanoic Acid
M.F.
M.W. 840.74
CAT# AR-L06137
CAS# NA
